Investigating how the SKIDA1 gene affects the development of acute myeloid leukemia.
The Role of SKIDA1 in Acute Myeloid Leukemia Initiation and Maintenance
This study is looking at how a specific gene called SKIDA1 affects the development of acute myeloid leukemia (AML) in infants, using mouse models to see what happens when this gene is removed, which could help find new ways to treat this type of leukemia.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10913288 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of the SKIDA1 gene in the initiation and maintenance of acute myeloid leukemia (AML), particularly in infants. The study examines how MLL fusion proteins, which are linked to AML, interact with neonatal hematopoietic progenitor cells to promote leukemia. By using mouse models, researchers will explore the effects of deleting the SKIDA1 gene on blood cell development and leukemia progression. This could provide insights into potential therapeutic targets for treating AML.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants and children diagnosed with acute myeloid leukemia, particularly those with MLL1 gene rearrangements.
Not a fit: Patients with acute myeloid leukemia who do not have MLL1 gene rearrangements may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating acute myeloid leukemia in infants and children.
How similar studies have performed: Previous research has shown promising results in understanding the genetic factors involved in leukemia, making this approach both relevant and potentially impactful.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Mendoza-Castrejon, Jonny — Washington University
- Study coordinator: Mendoza-Castrejon, Jonny
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.